| Literature DB >> 23999830 |
S S Hernes1, E Hagen, H Quarsten, B Bjorvatn, P S Bakke.
Abstract
We tested the hypothesis that the results of real-time polymerase chain reaction (PCR) analyses for respiratory viruses would reduce antibiotic treatment and length of stay in elderly patients hospitalized with respiratory infections. Within 24 h of hospital admission, a total of 922 patients aged ≥60 years were interviewed for symptoms of ongoing respiratory tract infection. Symptomatic patients were swabbed for oropharyngeal/nasopharyngeal presence of viral pathogens immediately by members of the study group. During a 2-month period, non-symptomatic volunteers among interviewed patients were swabbed as well (controls). Oropharyngeal/nasopharyngeal swabs were analyzed with real-time PCR for nine common respiratory viruses. A total of 147 out of 173 symptomatic patients and 56 non-symptomatic patients (controls) agreed to participate in the study. The patients were allocated to three cohorts: (1) symptomatic and PCR-positive (S/PCR+), (2) symptomatic and PCR-negative (S/PCR-), or (3) non-symptomatic and PCR-negative (control). There were no non-symptomatic patients with a positive PCR result. A non-significant difference in the frequency of empiric antibiotic administration was found when comparing the S/PCR+ to the S/PCR- cohort; 16/19 (84 %) vs. 99/128 (77 %) (χ(2) = 0.49). Antibiotic treatment was withdrawn in only two patients in the S/PCR+ cohort after receiving a positive viral diagnosis. The length of stay did not significantly differ between the S/PCR+ and the S/PCR- groups. We conclude that, at least in our general hospital setting, access to early viral diagnosis by real-time PCR had little impact on the antimicrobial treatment or length of hospitalization of elderly patients.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23999830 PMCID: PMC7088319 DOI: 10.1007/s10096-013-1963-0
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267
Inclusion criteria
| Inclusion criteria | |
|---|---|
| Symptomatic patients | Patients born in 1948 or earlier AND at least one of the following current symptoms with debut less than 3 weeks prior: • Nasal congestion or runny nose • Throat pain • Fever (>38 °C) • Malaise • Muscle pain • Self-diagnosis of “the common cold” • Diarrhea or eye infection combined with laboratory values supporting an infection |
| Non-symptomatic patients | Patients born in 1948 or earlier |
Characteristics of the study population
| S/PCR+ | S/PCR− | Control |
| |
|---|---|---|---|---|
| Number of patients | 19 | 128 | 56 | |
| Male gender, % | 42.1 | 60.2 | 66.1 | 0.183a |
| Age, mean (SD), years | 79 (8) | 76 (9) | 71 (9) | 0.002b |
| Smoking, % | 27.8 | 28.1 | 28.6 | 0.997a |
| Living in a nursing home, % | 21.1 | 11.3 | 1.8 | 0.027a |
| Leukocyte count at admission, mean (SD), G/L | 10.3 (6.0) | 12.4 (5.8) | 8.22 (2.6) | 0.000b |
| Maximum CRP, median (25th/75th percentile) | 60.0 (39/140) | 119.0 (56.5/227) | 11.5 (2/44) | <0.001b |
| Pneumonia at admission, % | 37 | 31 | 2 | <0.001a |
| In-hospital antibiotic treatment, % | 84 | 77 | 14 | <0.001a |
| Total CIRS-G score, median, (25th/75th percentile) | 11 (8/14) | 12 (9/16) | 11 (8/15) | 0.739a |
| CIRS-G respiratory, median (25th/75th percentile) | 2 (0/4) | 3 (0/4) | 0 (0/2) | <0.001a |
| CIRS-G cardiac, median, (25th/75th percentile) | 2 (1/2) | 2 (0/3) | 3 (0/3) | 0.010a |
| CCI, median (25th/75th percentile) | 1 (0/2) | 2 (1/2) | 1 (1/2) | 0.525a |
| Length of hospitalization, median (25th/75th percentile) | 3.9 (2.7/7.2) | 3.9 (2.3/6.8) | 2.2 (1.2/3.8) | 0.001c |
Characteristics of the study population divided into three groups: symptomatic and PCR-positive (S/PCR+), symptomatic and PCR-negative (S/PCR−), and non-symptomatic control (control)
CIRS-G Modified Cumulative Illness Rating Scale for Geriatrics; CCI Charlson comorbidity index
aPearson’s Chi-squared test
bOne-way analysis of variance (ANOVA)
cCox regression
Fig. 1Cumulative length of stay in the three cohorts. Length-of-stay analysis was performed by Cox regression. The length of stay differed significantly between the three cohorts (p < 0.001), but not when comparing the two symptomatic cohorts S/PCR+ and S/PCR− (p = 0.39)
The patients’ self-reported symptoms at the time of study inclusion
| S/PCR+ | S/PCR− |
| |
|---|---|---|---|
| Cough, % | 100 (19/19)a | 71.5 (89/125)a | 0.004 |
| Fever, anamnestic, % | 73.7 (14/19)a | 60.8 (76/125)a | 0.321 |
| Phlegm, % | 52.9 (9/17)a | 50.4 (59/117)a | 1.000 |
| Nasal discharge, % | 52.6 (10/19)a | 31.2 (39/125)a | 0.075 |
| Sore throat, % | 42.1 (8/19)a | 21.6 (27/125)a | 0.081 |
| No. of symptomatic days, mean (SD) | 5.8 (3.8) | 5.7 (5.3) | 0.940 |
Persistent, self-reported symptoms at the time of study inclusion, lasting less than 3 weeks. A comparison between the two groups was performed by the use of Fisher’s exact two-sided test, with significant p-values at < 0.05
aNumber of patients reporting symptoms/total number of patients